ASX announcements


ASX announcements

Date Title
Thursday, 23rd November 2017 Paradigms Two Arthritis Phase 2 Clinical Trials on Schedule Download
Thursday, 16th November 2017 Appendix 3B and Cleansing Notice Download
Wednesday, 15th November 2017 Change in substantial holding Download
Wednesday, 15th November 2017 Change of Director's Interest Notice Download
Wednesday, 15th November 2017 Cleansing Notice - Section 708A Download
Tuesday, 14th November 2017 Paradigms ACL Phase 2 Clinical Trial Success Download
Monday, 13th November 2017 Appendix 3B Download
Friday, 10th November 2017 Results of Meeting Download
Friday, 10th November 2017 CEO Update Download
Monday, 6th November 2017 PAR Successfully Completes A$5.75m Placement Download
Thursday, 2nd November 2017 Trading Halt Download
Thursday, 2nd November 2017 PAR Updated Corporate Presentation Download
Tuesday, 31st October 2017 Appendix 4C - quarterly Download
Monday, 30th October 2017 First Participant Dosed in PARs Phase 2b OA Clinical Trial Download
Wednesday, 11th October 2017 Response to ASX Query Download
Tuesday, 10th October 2017 Notice of Annual General Meeting/Proxy Form Download
Tuesday, 10th October 2017 PAR REPORTS PAIN REDUCTION IN 83% OF OSTEOARTHRITIS PATIENTS Download
Thursday, 28th September 2017 Appendix 3B Download
Tuesday, 19th September 2017 PARs Osteoarthritis Phase 2 Receives Ethics Approval Download
Thursday, 14th September 2017 Paradigm Phase 2 Ross River Virus Clinical Trial Update Download
Monday, 11th September 2017 A PARADIGM SHIFT IN TREATING OSTEOARTHRITIS PAIN Download
Tuesday, 29th August 2017 Appendix 4G Download
Tuesday, 29th August 2017 Appendix 4E and 2017 Annual Report Download
Monday, 21st August 2017 Appendix 3B Download
Wednesday, 9th August 2017 Paradigm (PAR) - First Ross River Trial Participant Treated Download
Thursday, 3rd August 2017 Shares released from escrow Download
Friday, 28th July 2017 Appendix 4C - quarterly Download
Monday, 10th July 2017 Paradigm To Commence Phase 2 Ross River Virus Clinical Trial Download
Tuesday, 4th July 2017 Appendix 3B Download
Wednesday, 28th June 2017 Change in substantial holding Download
Monday, 26th June 2017 Change of Director's Interest Notice Download
Tuesday, 20th June 2017 Paradigm Enters Heart Failure Market Download
Monday, 19th June 2017 Q and A on Hay Fever Program Download
Friday, 16th June 2017 Hay Fever Trial Update Download
Thursday, 15th June 2017 Trading Halt Download
Monday, 22nd May 2017 Paradigm Receives Ethics Approval for Ross River Trial Download
Tuesday, 16th May 2017 Paradigms preclinical hay fever trial published Download
Monday, 15th May 2017 Paradigm Non-Deal Roadshow Presentation Download
Thursday, 11th May 2017 Paradigm Government grant for Ross River virus research Download
Friday, 28th April 2017 Paradigm March Quarter Update & Appendix 4C Download
Thursday, 23rd March 2017 Final participant treated in Phase 2 hay fever trial Download
Wednesday, 22nd March 2017 Paradigm receives $1.34 million R&D tax incentive rebate Download
Tuesday, 21st March 2017 Paradigm Presents to Asian Investors Download
Tuesday, 7th March 2017 Paradigm Update Ross River Virus Clinical Trial Download
Thursday, 2nd March 2017 Broker Research Report for Paradigm Biopharma Download
Friday, 24th February 2017 Half Year Accounts Download
Tuesday, 7th February 2017 Appendix 3B Download
Tuesday, 31st January 2017 Quarterly Cashflow Report Download
Wednesday, 25th January 2017 Recruitment complete in Paradigms hay fever clinical trial Download
Friday, 20th January 2017 Shares released from escrow Download
Thursday, 19th January 2017 Appendix 3B Download